Thomas Stauffer Larsen

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Peter J. Campbell, E. Joanna Baxter, Philip Beer et al. · Blood · 2006 · 295 citations · Full text

Life Sciences, Genetics, Hematology +17

The JAK2 V617F mutation involves B‐ and T‐lymphocyte lineages in a subgroup of patients with Philadelphia‐chromosome negative chronic myeloproliferative disorders

Thomas Stauffer Larsen, Jacob Haaber Christensen, Hans Carl Hasselbalch et al. · British Journal of Haematology · 2007 · 160 citations

Medicine, Genetics, Hematology +17

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis – impact on disease phenotype

Thomas Stauffer Larsen, Niels Pallisgaard, Michael Møller et al. · European Journal Of Haematology · 2007 · 145 citations

Medicine, Genetics, Hematology +12

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

Tarec Christoffer El‐Galaly, Chan Y. Cheah, Mette Dahl Bendtsen et al. · European Journal of Cancer · 2018 · 136 citations · Full text

Medicine, Neurology, Oncology +11

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen et al. · Haematologica · 2019 · 105 citations · Full text

Medicine, Hematology, Pharmacology +15